Compliance
Responsible supply starts before quotation.
Product status depends on the substance, presentation, intended use, buyer and destination. Each requirement is reviewed on those facts.
Businesses, professionals and institutions can enquire. Product-specific commercial detail follows the checks applicable to that request.
Who can enquire
PeptidePharmacies accepts product enquiries from businesses, professionals and institutions. Organisation and qualification details are required so every request can be reviewed against the specific product, buyer, destination and proposed context before availability, pricing or supply is confirmed.
How product review works
Named sourcing references and compliance-approved product records are different states. An owner-authorised, unclassified name may appear only as a clearly labelled, noindex enquiry aid with no stock, specification, permitted-use or supply claim. Tier 1–2 records may be described as approved only after qualified review. Restricted records remain behind verified-buyer access, and prohibited records do not appear publicly.
Destination checks
No destination is represented as served until the jurisdiction matrix is approved. An enquiry records the intended destination so the team can review the buyer's status, product classification, import requirements, export controls, sanctions and necessary documents together.
What we will not do
- Confirm supply before the applicable product, buyer and destination checks are complete.
- Make therapeutic, performance, efficacy or safety claims.
- Provide dosing, administration or clinical guidance.
- Confirm supply where the buyer or destination requirements are unresolved.
- Misdescribe goods or alter documentation for customs purposes.
Reviewed supply modelLegal-entity, licence and served-market details will be published here only after documentary verification. Their absence is deliberate.